Cargando…

Apilimod Inhibits the Production of IL-12 and IL-23 and Reduces Dendritic Cell Infiltration in Psoriasis

Psoriasis is characterized by hyperplasia of the epidermis and infiltration of leukocytes into both the dermis and epidermis. IL-23, a key cytokine that induces T(H)17 cells, has been found to play a critical role in the pathogenesis of psoriasis. Apilimod is a small-molecule compound that selective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wada, Yumiko, Cardinale, Irma, Khatcherian, Artemis, Chu, John, Kantor, Aaron B., Gottlieb, Alice B., Tatsuta, Noriaki, Jacobson, Eric, Barsoum, James, Krueger, James G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320873/ https://www.ncbi.nlm.nih.gov/pubmed/22493730 http://dx.doi.org/10.1371/journal.pone.0035069

Ejemplares similares

Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis
por: Chamian, Francesca, et al.
Publicado: (2007)

First-In-Human, Phase 1, Randomized, Dose-Escalation Trial with Recombinant Anti–IL-20 Monoclonal Antibody in Patients with Psoriasis
por: Gottlieb, Alice B., et al.
Publicado: (2015)

The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection
por: Nelson, Elizabeth A., et al.
Publicado: (2017)

The PIKfyve Inhibitor Apilimod: A Double-Edged Sword against COVID-19
por: Baranov, Maksim V., et al.
Publicado: (2020)

Apilimod alters TGFβ signaling pathway and prevents cardiac fibrotic remodeling
por: Cinato, Mathieu, et al.
Publicado: (2021)

Apilimod activates the NLRP3 inflammasome through lysosome-mediated mitochondrial damage
por: Hou, Yingting, et al.
Publicado: (2023)

Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses
por: Zaba, Lisa C., et al.
Publicado: (2008)

Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses
por: Zaba, Lisa C., et al.
Publicado: (2007)

The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
por: Brembilla, Nicolo Costantino, et al.
Publicado: (2018)

The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis
por: Madonna, Stefania, et al.
Publicado: (2019)

The role of IL-23 in the immunopathogenesis of psoriasis
por: Meglio, Paola Di, et al.
Publicado: (2010)

Regulation of IL-22BP in psoriasis
por: Voglis, Stefanos, et al.
Publicado: (2018)

The Role of IL-17 Cytokines in Psoriasis
por: Mosca, Megan, et al.
Publicado: (2021)

IL-17A, IL-22, IL-6, and IL-21 Serum Levels in Plaque-Type Psoriasis in Brazilian Patients
por: de Oliveira, Priscilla Stela Santana, et al.
Publicado: (2015)

Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN
por: Keermann, Maris, et al.
Publicado: (2015)

Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells
por: Yao, Yongxue, et al.
Publicado: (2005)

Single-cell analysis of human skin identifies CD14(+) type 3 dendritic cells co-producing IL1B and IL23A in psoriasis
por: Nakamizo, Satoshi, et al.
Publicado: (2021)

IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis
por: Wang, Claire Q.F., et al.
Publicado: (2013)

Post-Therapeutic Relapse of Psoriasis after CD11a Blockade Is Associated with T Cells and Inflammatory Myeloid DCs
por: Johnson-Huang, Leanne M., et al.
Publicado: (2012)

Targeting IL-23 in psoriasis: current perspectives
por: Fotiadou, Christina, et al.
Publicado: (2018)

The contribution of IL-17 to the development of autoimmunity in psoriasis
por: Furue, Masutaka, et al.
Publicado: (2019)

Signalling of multiple interleukin (IL)‐17 family cytokines via IL‐17 receptor A drives psoriasis‐related inflammatory pathways
por: Tollenaere, M.A.X., et al.
Publicado: (2021)

Suppression of IL‐12/IL‐23 p40 subunit in the skin and blood of psoriasis patients by Tofacitinib is dependent on active interferon‐γ signaling in dendritic cells: Implications for the treatment of psoriasis and interferon‐driven diseases
por: Vincken, Nanette L. A., et al.
Publicado: (2022)

An Analysis of IL-10, IL-17A, IL-17RA, IL-23A and IL-23R Expression and Their Correlation with Clinical Course in Patients with Psoriasis
por: Kutwin, Magdalena, et al.
Publicado: (2021)

CRL4(DCAF2) negatively regulates IL-23 production in dendritic cells and limits the development of psoriasis
por: Huang, Tao, et al.
Publicado: (2018)

Compositional Alteration of Gut Microbiota in Psoriasis Treated with IL-23 and IL-17 Inhibitors
por: Huang, Yu-Huei, et al.
Publicado: (2023)

Therapeutic effect of the potent IL-12/IL-23 inhibitor STA-5326 on experimental autoimmune uveoretinitis
por: Keino, Hiroshi, et al.
Publicado: (2008)

IL-17 Induces an Expanded Range of Downstream Genes in Reconstituted Human Epidermis Model
por: Chiricozzi, Andrea, et al.
Publicado: (2014)

Low rotational barriers for the most dynamically active methyl groups in the proposed antiviral drugs for treatment of SARS-CoV-2, apilimod and tetrandrine
por: Mamontov, Eugene, et al.
Publicado: (2021)

Serum Levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in Patients With Active Psoriasis and Correlation With Disease Severity
por: Arican, Ozer, et al.
Publicado: (2005)

Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells
por: Ma, Xiaojing, et al.
Publicado: (2015)

Erratum to: A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis
por: Campa, Molly, et al.
Publicado: (2016)

Genomewide Scan Reveals Association of Psoriasis with IL-23 and NF-κB Pathways
por: Nair, Rajan P., et al.
Publicado: (2009)

Deep Sequencing of the T-cell Receptor Repertoire Demonstrates Polyclonal T-cell Infiltrates in Psoriasis
por: Harden, Jamie L., et al.
Publicado: (2015)

The role of IL‐23 and the IL‐23/T(H)17 immune axis in the pathogenesis and treatment of psoriasis
por: Girolomoni, G., et al.
Publicado: (2017)

IL-36 signaling in keratinocytes controls early IL-23 production in psoriasis-like dermatitis
por: Goldstein, Jérémie D, et al.
Publicado: (2020)

Safety of selective IL‐23p19 inhibitors for the treatment of psoriasis
por: Crowley, J.J., et al.
Publicado: (2019)

TARGETING IL-23: INSIGHTS INTO THE PATHOGENESIS AND THE TREATMENT OF PSORIASIS
por: Lima, Hermenio Cavalcante, et al.
Publicado: (2010)

Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis
por: Haugh, Isabel M, et al.
Publicado: (2018)

Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra
por: Conti, Pio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pk1dqbo6t53uoh1cc3uku06j47